Investing Profile
Brett Chevalier
InvestorVC
Chief Scientific Officer at Anterra Capital
anterracapital.com/team/Cambridge, Massachusetts
Your Intro Paths to Brett Chevalier
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Brett is a member of
Massachusetts Institute of Technology Network
617 CONNECTIONS
Massachusetts Institute of Technology Network
617 CONNECTIONS
University of Washington Network
148 CONNECTIONS
University of Washington Network
148 CONNECTIONS
Flagship Pioneering Network
99 CONNECTIONS
Find Brett Chevalier on
cbCurrent Investing Position
Investment Range
$1M - $20.0M
Sweet Spot
$5.0M
Current Fund Size
$260M
Brett Chevalier is on these Sector & Stage Rankings
Brett Chevalier's Experience
Senior Scientist (Systems Biology) Agilent TechnologiesPresent
Research Scientist Whitehead InstitutePresent
New Venture Associate Flagship PioneeringPresent
New Venture Associate Flagship VenturesPresent
Advisor CorviumPresent
Advisor Corvium (Acquired by Neogen)Present
Head Of Operations CAMP4 TherapeuticsPresent
Chief Scientific Officer Anterra CapitalPresent
Board Observer BiomEdit, Inc.Present
Board Observer BiomEditPresent
Founder and Chief Scientific Officer Corvium (Acquired by Neogen)Present
Founder and Chief Scientific Officer CorviumPresent
Scientific Co-Founder, SAB, Board Observer Animol Discovery, Inc.Present
Scientific Co-Founder, Interim VP Ops and CSO, Board Observer Orogen TherapeuticsPresent
Brett Chevalier's Education
Carleton College BA Biology
University of Washington PhD Molecular and Cellular Biology
University of Washington PhD Protein Design and Engineering
Massachusetts Institute of Technology Postdoc Stem Cells and Genomics
Massachusetts Institute of Technology Merck LSRF Fellow Stem and iPS cells, cell fate/state regulatory circuitry, systems biology
Investors who invest with Brett Chevalier
Sign in with Google →Scouts & Angels Affiliated With Brett Chevalier
Sign in with Google →